Interventional/Surgery
COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
The trial is the first randomized controlled trial to show a safety advantage of a DES, investigators say.

Paris, France - Use of a bioerodable polymer, biolimus-eluting stent (BES) in patients with ST-elevation MI (STEMI) can radically reduce the rate of major adverse cardiac events (MACE) at one year, the COMFORTABLE-AMI study suggests.

Dr Lorenz Räber (Berne University Hospital, Switzerland), who presented the results here at EuroPCR 2012, estimated that only 24 patients would need to be treated with BES to avoid one major event. The major driver of this benefit was a reduction in both target vessel reinfarction and target lesion revascularization, Räber noted.
Read full article »

Acute Coronary Syndromes
One troponin test to identify low-risk patients fast
May 18, 2012 13:15 EDT

Medscape Medical News
FDA to review CV risk with azithromycin
May 17, 2012 13:00 EDT

Acute Coronary Syndromes
Air pollutants mediate effects on heart health through inflammation and thrombosis
May 16, 2012 17:15 EDT

Arrhythmia/EP
Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT

Features
So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT

Interventional/Surgery
COMPARE II: Nobori biolimus stent matches everolimus stents in all-comers
May 16, 2012 10:15 EDT

Editorial programs
Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team
View all »
Starting with ASCERT, a look at observational studies
Starting with ASCERT, a look at observational studies
May 8, 2012 08:53 EDT
The creative destruction of medicine with Dr Eric Topol
The creative destruction of medicine with Dr Eric Topol
Apr 24, 2012 13:30 EDT
Statins, diabetes, and the FDA
Statins, diabetes, and the FDA
4 COMMENTS - Apr 17, 2012 13:00 EDT
View all »Collections
heartwire collections groups our most compelling cardiology news coverage and editorial content by popular themes. Find everything on a single topic, in one place, with one click.
Antiplatelet up-and-comers
The quest for ever-more effective drugs to decrease platelet aggregation and reduce the...
Erectile dysfunction and CHD
Years ago, Viagra made the unexpected transition from hypertension and angina drug...
Aspirin and primary prevention
Long considered an essential agent for primary cardiovascular disease prevention...
Dabigatran: A chronology
The presentation of the RE-LY results at the 2009 ESC meeting, showing that dabigatran...
Drugs, money, and glory: Is cancer beating cardiovascular disease?
Heart disease still tops the charts as the number-one killer in most developed...
CV & GI Risk
The satellite programs of the CV & GI Risk section are accredited by Medscape. The steering committee members are active in overseeing the development and direction of this educational series.
The Heart of a Woman
The Heart of a Woman
The Heart of a Woman
2 COMMENTS - Apr 27, 2009 13:25 EDT
Resource Center (view all)